Flora Competitors

Delisted . USA . 
Stock . Flora Growth Corp
FLGCDelisted Stock  USD 8.95  2.02  18.41%   
Flora Growth Corp competes with China Pharma, Autonomix Medical, Redhill Biopharma, Kala Pharmaceuticals, and Oragenics; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Flora Growth competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Flora Growth to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Flora Growth Correlation with its peers.

Flora Growth vs Mainz Biomed Correlation

Very weak diversification

The correlation between Flora Growth Corp and MYNZ is 0.47 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Flora Growth Corp and MYNZ in the same portfolio, assuming nothing else is changed.

Moving against Flora Stock

  0.64DD Dupont De Nemours Earnings Call This WeekPairCorr
  0.61PPERY Bank Mandiri Persero Earnings Call This WeekPairCorr
  0.54AA Alcoa CorpPairCorr
  0.53TLKMF Telkom Indonesia TbkPairCorr
  0.53TLK Telkom Indonesia TbkPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.397.7919.26
Details
Intrinsic
Valuation
LowRealHigh
0.367.2118.68
Details
Naive
Forecast
LowNextHigh
0.2010.0321.49
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.067.169.26
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Flora Growth. Your research has to be compared to or analyzed against Flora Growth's peers to derive any actionable benefits. When done correctly, Flora Growth's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Flora Growth Corp.

Flora Growth Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Flora Growth and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Flora and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Flora Growth Corp does not affect the price movement of the other competitor.

High positive correlations

AKAN
+ 0.95
ENSC
ENSC
+ 0.89
AMIX
AMIX
+ 0.87
CPHI
AKAN
+ 0.87
AIM
AKAN
+ 0.86
AMIX
AKAN
+ 0.84
OGEN
  

High negative correlations

MYNZ
- 0.39
KZIA
ENSC
- 0.19
RDHL
RDHL
- 0.18
AMIX
KZIA
- 0.12
OGEN
KZIA
- 0.08
RDHL
RDHL
- 0.04
CPHI

Risk-Adjusted Indicators

There is a big difference between Flora Stock performing well and Flora Growth Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Flora Growth's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CPHI  3.06 (0.59) 0.00  10.68  0.00 
 0.00 
 6.67 
(6.72)
 18.93 
AMIX  5.11 (1.20) 0.00  1.73  0.00 
 0.00 
 7.50 
(11.93)
 74.93 
RDHL  3.67 (0.30) 0.00 (0.09) 0.00 
 0.00 
 7.77 
(6.14)
 46.87 
KALA  5.77 (0.30) 0.00 (0.34) 0.00 
 0.00 
 12.28 
(10.77)
 59.48 
OGEN  3.01 (0.65) 0.00 (1.12) 0.00 
 0.00 
 4.55 
(7.53)
 19.90 
ENSC  3.70 (1.53) 0.00 (1.64) 0.00 
 0.00 
 5.94 
(10.78)
 23.86 
AIM  4.31 (1.19) 0.00 (0.34) 0.00 
 0.00 
 7.69 
(10.32)
 29.72 
AKAN  7.04 (2.60) 0.00  2.54  0.00 
 0.00 
 11.11 
(19.14)
 61.73 
KZIA  7.93  0.16  0.03  0.07  10.16 
(8.53)
 14.69 
(18.36)
 78.79 
MYNZ  4.15 (0.42) 0.00 (0.12) 0.00 
 0.00 
 9.48 
(6.67)
 21.62 

Flora Growth Competitive Analysis

The better you understand Flora Growth competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Flora Growth's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Flora Growth's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
FLGC CPHI AMIX RDHL KALA OGEN ENSC AIM AKAN KZIA
 18.41 
 8.95 
Flora
 7.08 
 1.05 
China
 4.00 
 0.42 
Autonomix
 3.94 
 1.22 
Redhill
 0.000006 
 0.53 
Kala
 3.30 
 0.81 
Oragenics
 0.55 
 0.73 
Ensysce
 5.74 
 1.15 
AIM
 3.91 
 1.23 
Akanda
 1.37 
 5.94 
Kazia
Market Volatility
(90 Days Market Risk)
Very risky
Extremely Dangerous
Extremely Dangerous
Very steady
Out of control
Dangerous
Relatively risky
Risky
Abnormally volatile
Risky
Market Performance
(90 Days Performance)
Weak
Weakest
Weakest
Soft
Weakest
Weakest
Weakest
Weakest
Weakest
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Strong
Risky
Risky
Risky
Fair
Risky
Risky
Risky
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Buy
Strong Buy
Strong Buy
Hold
Buy
Strong Buy
Not Available
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Hold
Strong Sell
Cautious Hold
Strong Sell
Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Current Ratio
3.18
0.75
N/A
0.98
2.54
12.31
0.87
14.21
0.48
1.62
Net Asset
26.23 M
14.89 M
9.81 M
18.04 M
55.48 M
1.47 M
5.6 M
8.61 M
7.91 M
6.06 M
Profit Margin
-0.28
-0.83
N/A
-0.98
N/A
N/A
-2.44
N/A
-2.66
N/A
EBITDA
(15.1 M)
(1.96 M)
(11.05 M)
(7.59 M)
(40.98 M)
(10.54 M)
(6.73 M)
(16.49 M)
(3.03 M)
(13.28 M)
Operating Margin
-0.33
-0.49
N/A
-1.07
N/A
N/A
-7.59
-94.12
-4.44
-2.68
Current Valuation
11.59 M
9.38 M
(7.93 M)
3.84 M
23.89 M
(7.59 M)
1.33 M
3.61 M
767.63 K
66.37 M
Price To Book
0.33
0.73
0.43
203.21
8.34
0.35
2.17
2.72
0.82
3.09
Retained Earnings
(158.14 M)
(44.03 M)
(50.38 M)
(414.8 M)
(667.92 M)
(216.79 M)
(129.54 M)
(426.83 M)
(57.46 M)
(134.83 M)
Current Asset
N/A
20.99 M
N/A
60.51 M
84.65 M
5.64 M
N/A
15.73 M
N/A
35.14 M
Beta
1.87
1.04
N/A
4.86
-2.44
0.9
1.16
1.21
1.7
1.75
Number Of Employees
64
224
8
35
38
3
7
21
N/A
6
Shares Outstanding
741.26 K
3.26 M
6.91 M
5.11 M
27.85 M
4.17 M
3.63 M
3.2 M
2.1 M
11.34 M
Cash Flow From Operations
(5.03 M)
(466.36 K)
(8.26 M)
(9.37 M)
(29.38 M)
(8.6 M)
(7.5 T)
(14.89 M)
(3.98 M)
(13.28 M)
Total Debt
4.9 M
3.59 M
1.71 M
356 K
32.25 M
328.53 K
301.66 K
2.94 M
352.81 K
396 K
Return On Equity
-0.45
-0.53
-3.52
-17.09
-7.08
-1.69
-2.94
-31.39
-0.61
-38.92
Return On Asset
-0.18
-0.16
-1.59
-0.25
-0.66
-0.71
-1.1
-0.95
-0.29
-0.64
Number Of Shares Shorted
22.72 K
4.86 K
658.69 K
175.26 K
430.67 K
57.84 K
205.1 K
61.95 K
74.78 K
86.75 K
Book Value Per Share
91.17
2.38
1.04
-2.45
-1.17
2.38
0.38
-2.2
22.67
-3.61
Current Liabilities
N/A
12.95 M
N/A
5.51 M
10.53 M
1.05 M
N/A
6.65 M
N/A
5.49 M
Total Asset
26.23 M
14.89 M
9.81 M
18.04 M
55.48 M
1.47 M
5.6 M
8.61 M
7.91 M
6.06 M
Debt To Equity
0.059
2.63
N/A
9.89
4.77
0.023
6.91
0.02
0.027
0.39
Short Ratio
0.88
0.42
0.08
0.14
0.18
0.98
1.61
0.39
0.09
0.33
Target Price
30.0
3.0
6.6
19000.0
1.5
2.0
19.23
13.99
N/A
18.94
Shares Owned By Institutions
2.05
3.6
4.77
0.55
18.4
13.17
10.58
4.94
1.89
7.8
Market Capitalization
5.81 M
4.96 M
2.75 M
6.24 M
14.76 M
3.5 M
2.64 M
3.68 M
2.69 M
66.43 M
Price To Earning
N/A
-0.89
N/A
-3.67
-0.52
-2.28
N/A
12.5
N/A
-5.35
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
-0.04
N/A
N/A
Price To Sales
0.37
1.4
N/A
0.65
1.16
89.28
0.59
32.87
3.22
36.32
Net Income
(15.91 M)
(4.74 M)
(11.41 M)
(8.27 M)
(38.51 M)
(10.57 M)
(7.99 M)
(17.32 M)
(4.1 M)
(20.7 M)
Earnings Per Share
-41.09
-1.47
-4.51
N/A
-5.64
49.36
-6.32
-18.16
154.84
-13.3
Shares Owned By Insiders
16.61
19.04
6.71
N/A
0.23
2.38
0.29
3.85
N/A
1.38
Revenue
59.51 M
4.53 M
N/A
8.04 M
N/A
N/A
5.21 M
170 K
836.66 K
42 K
Working Capital
931 K
(1.75 M)
7.9 M
(10.31 M)
35.84 M
(211.88 K)
3.14 M
(5.36 M)
1.42 M
(9.12 M)
Cash And Equivalents
10.27 M
2.24 M
N/A
28.86 M
44.57 M
17.87 M
3.15 M
1.7 M
N/A
7.36 M
Cash Per Share
0.13
0.04
N/A
0.55
30.44
0.15
0.1
0.76
N/A
0.49
Gross Profit
12.08 M
(903.31 K)
N/A
6.16 M
1.33 M
(3.39 M)
(6.08 M)
17 K
208.38 K
1.83 M
Day Typical Price
8.97
1.12
0.41
1.24
0.53
0.81
0.72
1.17
1.29
5.86
Accumulation Distribution
0.18
0.17
0.0714
0.0769
0.0556
0.0595
0.0548
0.0496
0.13
0.17
Market Facilitation Index
1.73
0.22
0.03
0.1
0.03
0.05
0.04
0.06
0.18
1.07
Daily Balance Of Power
(1.17)
(0.36)
0.5333
(0.50)
(0.000001)
(0.55)
(0.10)
(1.17)
(0.28)
0.0748
Period Momentum Indicator
(2.02)
(0.08)
0.016
(0.05)
N/A
(0.03)
(0)
(0.07)
(0.05)
0.08
Rate Of Daily Change
0.82
0.93
1.04
0.96
1.0
0.97
0.99
0.94
0.96
1.01
Day Median Price
8.98
1.16
0.41
1.25
0.53
0.82
0.71
1.18
1.32
5.82
Price Action Indicator
(1.04)
(0.15)
0.019
(0.06)
0.005
(0.02)
0.014
(0.07)
(0.11)
0.17
Relative Strength Index
54.15
36.72
38.37
49.9
43.68
41.52
28.24
39.74
31.34
45.01
Coefficient Of Variation
(6,635)
(672.14)
(758.83)
(2,913)
(3,518)
(641.30)
(335.68)
(546.50)
(391.74)
3435.02
Mean Deviation
5.71
3.06
5.11
3.67
5.77
3.01
3.7
4.31
7.04
7.93
Jensen Alpha
(0.16)
(0.59)
(1.20)
(0.30)
(0.30)
(0.65)
(1.53)
(1.19)
(2.60)
0.164
Total Risk Alpha
(0.72)
(0.78)
(1.66)
(0.52)
(0.72)
(0.82)
(1.74)
(1.36)
(3.14)
(0.24)
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0296
Downside Variance
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
110.08
Standard Deviation
11.19
3.93
9.18
6.16
9.25
3.95
5.01
5.84
10.3
12.22
Kurtosis
29.1
0.0644
25.65
17.98
9.51
0.6043
0.854
2.21
4.73
4.92
Potential Upside
9.42
6.67
7.5
7.77
12.28
4.55
5.94
7.69
11.11
14.69
Treynor Ratio
0.3423
10.68
1.73
(0.09)
(0.34)
(1.12)
(1.64)
(0.34)
2.54
0.0665
Maximum Drawdown
30.99
18.93
74.93
46.87
59.48
19.9
23.86
29.72
61.73
78.79
Variance
125.31
15.41
84.29
37.96
85.64
15.63
25.06
34.14
106.03
149.29
Market Risk Adjusted Performance
0.3523
10.69
1.74
(0.08)
(0.33)
(1.11)
(1.63)
(0.33)
2.55
0.0765
Risk Adjusted Performance
(0)
(0.1)
(0.09)
(0.02)
(0.01)
(0.10)
(0.21)
(0.12)
(0.18)
0.0305
Skewness
4.4
(0.01)
4.0
3.03
2.4
0.1354
0.1359
0.0805
1.16
1.29
Semi Deviation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
10.16
Information Ratio
(0.02)
(0.16)
(0.14)
(0.04)
(0.03)
(0.17)
(0.31)
(0.19)
(0.26)
0.0254
Value At Risk
(12.32)
(6.72)
(11.93)
(6.14)
(10.77)
(7.53)
(10.78)
(10.32)
(19.14)
(18.36)
Expected Short fall
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(8.53)
Downside Deviation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
10.49
Semi Variance
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
103.24

Flora Growth Competition Performance Charts

Five steps to successful analysis of Flora Growth Competition

Flora Growth's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Flora Growth Corp in relation to its competition. Flora Growth's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Flora Growth in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Flora Growth's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Flora Growth Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Flora Growth position

In addition to having Flora Growth in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cash Cows Thematic Idea Now

Cash Cows
Cash Cows Theme
Entities with stable and reliable earnings or profits, which allows them to pay consistent dividends to their shareholders. The Cash Cows theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cash Cows Theme or any other thematic opportunities.
View All  Next Launch
Check out Flora Growth Correlation with its peers.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Flora Stock

If you are still planning to invest in Flora Growth Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Flora Growth's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY